Grace Therapeutics, Inc. (ACST)
1.93
+0.02
(+0.78%)
USD |
NASDAQ |
Oct 23, 16:00
Grace Therapeutics Net Income (Quarterly) : -15.79M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.79M |
| March 31, 2026 | -1.178M |
| December 31, 2025 | -2.315M |
| September 30, 2025 | -0.938M |
| June 30, 2025 | -3.362M |
| March 31, 2025 | 0.636M |
| December 31, 2024 | -4.155M |
| September 30, 2024 | -3.432M |
| June 30, 2024 | -2.617M |
| March 31, 2024 | -3.166M |
| December 31, 2023 | -2.391M |
| September 30, 2023 | -3.273M |
| June 30, 2023 | -4.023M |
| March 31, 2023 | -29.09M |
| December 31, 2022 | -3.889M |
| September 30, 2022 | -4.929M |
| June 30, 2022 | -4.524M |
| March 31, 2022 | -3.904M |
| December 31, 2021 | -3.778M |
| September 30, 2021 | 0.981M |
| June 30, 2021 | -3.118M |
| March 31, 2021 | -5.646M |
| December 31, 2020 | -3.22M |
| September 30, 2020 | -6.146M |
| June 30, 2020 | -4.666M |
| Date | Value |
|---|---|
| December 31, 2019 | -12.12M |
| September 30, 2019 | -21.16M |
| June 30, 2019 | -8.846M |
| March 31, 2019 | -12.64M |
| December 31, 2018 | -3.491M |
| September 30, 2018 | -17.38M |
| June 30, 2018 | -5.748M |
| March 31, 2018 | -6.436M |
| December 31, 2017 | -4.783M |
| September 30, 2017 | -3.592M |
| June 30, 2017 | -2.067M |
| November 30, 2016 | -1.808M |
| August 31, 2016 | -1.795M |
| May 31, 2016 | -2.426M |
| February 29, 2016 | -1.381M |
| November 30, 2015 | -1.660M |
| August 31, 2015 | -0.9704M |
| May 31, 2015 | -0.7798M |
| February 28, 2015 | -1.924M |
| November 30, 2014 | 2.697M |
| August 31, 2014 | -3.428M |
| May 31, 2014 | 1.234M |
| February 28, 2014 | -2.348M |
| November 30, 2013 | -3.706M |
| August 31, 2013 | -3.120M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| AbbVie, Inc. | 3.604B |
| Abeona Therapeutics, Inc. | -20.19M |
| America Great Health | -0.1662M |
| Acumen Pharmaceuticals, Inc. | -32.72M |
| Aardvark Therapeutics, Inc. | -14.39M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 15.79M |
| EPS Diluted (Quarterly) | -0.9143 |
| Enterprise Value | 17.65M |
| Earnings Yield | -61.32% |
| Normalized Earnings Yield | -36.06 |